Literature DB >> 30120949

Beta-secretase/BACE1 promotes APP endocytosis and processing in the endosomes and on cell membrane.

Mingguang Wang1, Tian Jing1, Xuan Wang1, Dan Yao2.   

Abstract

Amyloid-β proteins deposition and aggregation occur in extracellular space and form neuritic plaques in Alzheimer's disease (AD) brain. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)/ β-secretase and γ-secretase Presenilin 1 (PSEN1) conduct sequential cleavage of amyloid- β precursor protein (APP) and yield amyloid- β proteins. However the details of the interactions of APP with the enzymes and transportation of catalytic products are unclear. Here we reveal distinctive targeting patterns of the proteins in subcellular organelles in N2A cells. We find all three proteins co-localize in endosomes with APP and PSEN1 co-localize and associate on cell membrane and nucleus. By selectively knocking down BACE1 or PSEN 1 with siRNA, we discover that BACE1 functions as the enzyme initiating the first cleavage step and serves a scaffold for APP and PSEN1 endocytosis. PSEN1 knocking-down only leads to the reduction of BACE1 in cell membrane and nucleus. We conclude that BACE1 facilitates the transportation of APP and formation of the complex with γ-secretase, resulting in the stepwise cleavages of APP. After BACE1 cleavage APP binds to PSEN1 and transfers to cell membrane or nucleus for final processing and amyloid genesis.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid beta precursor protein (APP); Beta-secretase BACE1; Endocytosis; Presenilin 1(PSEN1)

Mesh:

Substances:

Year:  2018        PMID: 30120949     DOI: 10.1016/j.neulet.2018.08.016

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Impact of Cholesterol Concentration and Lipid Phase on Structure and Fluctuation of Amyloid Precursor Protein.

Authors:  George A Pantelopulos; Afra Panahi; John E Straub
Journal:  J Phys Chem B       Date:  2020-11-02       Impact factor: 2.991

2.  NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load.

Authors:  Theresa Pohlkamp; Xunde Xian; Connie H Wong; Murat S Durakoglugil; Gordon Chandler Werthmann; Takaomi C Saido; Bret M Evers; Charles L White; Jade Connor; Robert E Hammer; Joachim Herz
Journal:  Elife       Date:  2021-10-07       Impact factor: 8.713

3.  Super-resolution microscopy reveals majorly mono- and dimeric presenilin1/γ-secretase at the cell surface.

Authors:  Abril Angélica Escamilla-Ayala; Ragna Sannerud; Magali Mondin; Karin Poersch; Wendy Vermeire; Laura Paparelli; Caroline Berlage; Marcelle Koenig; Lucia Chavez-Gutierrez; Maximilian H Ulbrich; Sebastian Munck; Hideaki Mizuno; Wim Annaert
Journal:  Elife       Date:  2020-07-07       Impact factor: 8.140

4.  Herpes Simplex Virus Infection Increases Beta-Amyloid Production and Induces the Development of Alzheimer's Disease.

Authors:  Tianfang Ge; Yufei Yuan
Journal:  Biomed Res Int       Date:  2022-08-31       Impact factor: 3.246

5.  Multifunctional magnetite nanoparticles to enable delivery of siRNA for the potential treatment of Alzheimer's.

Authors:  Natalia Lopez-Barbosa; Juan G Garcia; Javier Cifuentes; Lina M Castro; Felipe Vargas; Carlos Ostos; Gloria P Cardona-Gomez; Alher Mauricio Hernandez; Juan C Cruz
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.